| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 27 | 27 | 26 | 26 | 25 | 25 | 33 | 25 | 24 | 30 |
| Gross Profit/Loss - EUR | -27 | -27 | -26 | -26 | -25 | -25 | -33 | -25 | -24 | -30 |
| Net Profit/Loss - EUR | -27 | -27 | -26 | -26 | -25 | -25 | -33 | -25 | -24 | -30 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Mediclinic Studii Clinice Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 881 | 801 | 761 | 721 | 682 | 644 | 597 | 575 | 548 | 515 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 881 | 801 | 761 | 721 | 682 | 644 | 597 | 575 | 548 | 515 |
| Shareholders Funds | -1.328 | -1.341 | -1.345 | -1.346 | -1.345 | -1.345 | -1.348 | -1.376 | -1.396 | -1.419 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.209 | 2.142 | 2.106 | 2.067 | 2.027 | 1.989 | 1.945 | 1.951 | 1.945 | 1.934 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7219 - 7219" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Mediclinic Studii Clinice Srl